These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 1767261
81. [Immunization against diphtheria and tetanus]. Ullberg-Olsson K. Lakartidningen; 1983 Mar 23; 80(12):1237-8. PubMed ID: 6865579 [No Abstract] [Full Text] [Related]
82. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids. Gupta RK, Siber GR. Dev Biol Stand; 1996 Mar 23; 86():207-15. PubMed ID: 8785950 [Abstract] [Full Text] [Related]
83. Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents. Bégué PC, Grimprel EM, Giovannangeli MD, Abitbol VI. Pediatr Infect Dis J; 1998 Sep 23; 17(9):804-9. PubMed ID: 9779766 [Abstract] [Full Text] [Related]
84. Safety and immunogenicity of single dose of tetanus-diphtheria (Td) vaccine among non/partially immune children against diphtheria and/or tetanus, Hyderabad, India, 2007. Bitragunta S, Murhekar MV, Chakravarti A, Verma V, Namjoshi GS, Parekh SS, Sharma HJ, Kumar BK, Gupte MD. Vaccine; 2010 Aug 23; 28(37):5934-8. PubMed ID: 20620169 [Abstract] [Full Text] [Related]
87. Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart. Embree J, Law B, Voloshen T, Tomovici A. Clin Vaccine Immunol; 2015 Mar 23; 22(3):282-90. PubMed ID: 25540274 [Abstract] [Full Text] [Related]
89. [State of the immunity against diphtheria, tetanus and whooping cough in children inoculated according to a disrupted vaccination schedule]. Maksimova NM, Sukhorukova NL, Basova NN, Gizatulina SS, Rudometkina MD. Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov 23; (11):121-5. PubMed ID: 4450853 [No Abstract] [Full Text] [Related]
90. [Postvaccinal antidiphtheria and antitetanus immunity in patients with systemic connective tissue diseases]. Vasil'eva GV, Kostinov MP, Lyskina GA, Magarshak OO, Slatinova OV. Zh Mikrobiol Epidemiol Immunobiol; 2004 Nov 23; (5):98-101. PubMed ID: 15554324 [Abstract] [Full Text] [Related]
92. Use of tetanus-diphtheria (Td) vaccine in children 4-7 years of age: World Health Organization consultation of experts. Desai S, Scobie HM, Cherian T, Goodman T, Expert Group on the Use of Td vaccine in Childhood. Vaccine; 2020 May 06; 38(21):3800-3807. PubMed ID: 31983584 [Abstract] [Full Text] [Related]
93. The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Simonsen O, Badsberg JH, Kjeldsen K, Møller-Madsen B, Heron I. Acta Pathol Microbiol Immunol Scand C; 1986 Apr 06; 94(2):77-82. PubMed ID: 3739720 [Abstract] [Full Text] [Related]
94. Effect on diphtheria immunity of combined tetanus and diphtheria booster vaccination in adults. Marlovits S, Stocker R, Efstratiou A, Broughton K, Kaider A, Vécsei V, Kollaritsch H. Eur J Clin Microbiol Infect Dis; 2000 Jul 06; 19(7):506-13. PubMed ID: 10968321 [Abstract] [Full Text] [Related]
97. Immunity to tetanus: tetanus antitoxin and anti-BIIb in human sera. German-Fattal M, Bizzini B, German A. J Biol Stand; 1987 Jul 06; 15(3):223-30. PubMed ID: 3611114 [Abstract] [Full Text] [Related]
100. Seroprotection rate in adults after 1-dose, 2-dose, and 3-dose series of a reduced-diphtheria-tetanus toxoid vaccine (Td) during a diphtheria outbreak in Thailand. Suntarattiwong P, Vandepitte WP, Singhamatr P, Chotpitayasunondh T. Vaccine; 2020 Feb 24; 38(9):2128-2131. PubMed ID: 31987691 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]